Achieve Life Sciences Inc (ACHV) is a Healthcare · Biotechnology company listed on NASDAQ. Price $7.97 (+0.76%), Market cap $0.54B, 52-week low–high $2.07 ~ $5.99.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Financial statements, price targets, institutional (13F) holdings and related news for Achieve Life Sciences Inc are updated in real time on BlackAll Trade.
Achieve Life Sciences Inc trades at $7.97 (+0.76%). Real-time quotes and charts are available on BlackAll Trade.
Achieve Life Sciences Inc has a market cap of about $0.54B.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company